Mediastinal Lymphoproliferative Disorders

被引:8
|
作者
Pina-Oviedo, Sergio [1 ]
机构
[1] Univ Arkansas Med Sci, Dept Pathol & Lab Serv, 4301 West Markham St,502, Little Rock, AR 72205 USA
关键词
Hodgkin lymphoma; mediastinal lymphoma; lymphoblastic lymphoma; Castleman disease; thymus; B-CELL LYMPHOMA; CLASSICAL HODGKIN LYMPHOMA; MARGINAL ZONE LYMPHOMA; THYMIC MALT LYMPHOMA; T-LYMPHOBLASTIC LYMPHOMA; REED-STERNBERG CELLS; TUMOR-SUPPRESSOR GENE; DEATH-LIGAND; TISSUE LYMPHOMA; EXTRAMEDULLARY PLASMACYTOMA;
D O I
10.1097/PAP.0000000000000305
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Lymphoproliferative disorders comprise 50% to 60% of all mediastinal malignancies in both children and adults. Primary mediastinal involvement is rare (similar to 5%), whereas secondary mediastinal involvement by systemic disease is more common (10% to 25%). Primary mediastinal disease is defined as involvement by a lymphoproliferative disorder of mediastinal lymph nodes, the thymus, and/or extranodal mediastinal organs without evidence of systemic disease at presentation. In this review, the clinical, radiologic, histopathologic, immunohistochemical, and genetic features of some of the most characteristic mediastinal lymphoproliferative disorders are presented. The entities discussed here include: classic Hodgkin lymphoma with emphasis on nodular sclerosis and mixed cellularity types, and non-Hodgkin lymphomas, including primary mediastinal (thymic) large B-cell lymphoma, mediastinal gray zone lymphoma, mediastinal diffuse large B-cell lymphoma, thymic marginal zone lymphoma, mediastinal plasmacytoma, T-lymphoblastic lymphoma, and anaplastic large cell lymphoma. Although not a malignant process, hyaline vascular Castleman disease is also discussed here as this disorder commonly involves the mediastinum. Despite multiple advances in hematopathology in recent decades, the day-to-day diagnosis of these lesions still requires a morphologic approach and a proper selection of immunohistochemical markers. For this reason, it is crucial for general pathologists to be familiar with these entities and their particular clinicoradiologic presentation.
引用
收藏
页码:307 / 334
页数:28
相关论文
共 50 条
  • [31] IMMUNOHISTOCHEMISTRY OF LYMPHOPROLIFERATIVE DISORDERS
    TUBBS, R
    FISHLEDER, A
    WEISS, R
    SAVAGE, R
    SEBEK, B
    WEICK, J
    LABORATORY INVESTIGATION, 1982, 46 (01) : A84 - A84
  • [32] CIRRHOSIS AND LYMPHOPROLIFERATIVE DISORDERS
    HEIMANN, R
    LANCET, 1971, 2 (7726): : 705 - &
  • [33] Gastrointestinal lymphoproliferative disorders
    Banks, P. M.
    HISTOPATHOLOGY, 2007, 50 (01) : 42 - 54
  • [34] CIRRHOSIS AND LYMPHOPROLIFERATIVE DISORDERS
    PATON, A
    LANCET, 1971, 2 (7718): : 259 - &
  • [35] CATEGORIZATION OF LYMPHOPROLIFERATIVE DISORDERS
    CRADDOCK, CG
    NEW ENGLAND JOURNAL OF MEDICINE, 1975, 292 (14): : 754 - 754
  • [36] LYMPHOPROLIFERATIVE DISORDERS IN THE THORAX
    TJHO, ETT
    NETHERLANDS JOURNAL OF MEDICINE, 1979, 22 (03): : 94 - 94
  • [38] Lymphoproliferative Disorders of the Lung
    Borie, Raphael
    Wislez, Marie
    Antoine, Martine
    Cadranel, Jacques
    RESPIRATION, 2017, 94 (02) : 157 - 175
  • [39] Differentiating fine needle aspiration biopsy (FNA) of thymic lesions presenting as anterior mediastinal masses lymphoproliferative disorders.
    Shin, HJ
    Katz, RL
    LABORATORY INVESTIGATION, 1997, 76 (01) : 206 - 206
  • [40] IMMUNOLOGICAL CHARACTERIZATION OF LYMPHOPROLIFERATIVE DISORDERS
    HUBER, H
    MICHLMAYR, G
    HUBER, C
    FALKENSAMMER, M
    KLINISCHE WOCHENSCHRIFT, 1976, 54 (15): : 699 - 708